ReviewFrontiers in immunology2021

Targeting Myeloid-Derived Suppressor Cells to Enhance the Antitumor Efficacy of Immune Checkpoint Blockade Therapy.

Xueyan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.